Cardiol Therapeutics (CRDL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2025 | 12-2024 | 09-2024 | 06-2024 | 03-2024 | |
| Operating Expenses | 8,429 | 7,141 | 10,365 | 5,657 | 6,231 |
| Operating Income | -8,429 | -7,141 | -10,365 | -5,657 | -6,231 |
| Other Income | 141 | 1,325 | 1,035 | 841 | -574 |
| Pre-tax Income | -8,288 | -5,816 | -9,330 | -4,816 | -6,805 |
| Net Income Continuous | -8,288 | -5,816 | -9,330 | -4,816 | -6,805 |
| Net Income | $-8,288 | $-5,816 | $-9,330 | $-4,816 | $-6,805 |
| EPS Basic Total Ops | -0.10 | -0.06 | -0.13 | -0.07 | -0.10 |
| EPS Basic Continuous Ops | -0.10 | -0.07 | -0.13 | -0.07 | -0.10 |
| EPS Diluted Total Ops | -0.10 | -0.06 | -0.13 | -0.07 | -0.10 |
| EPS Diluted Continuous Ops | -0.10 | -0.07 | -0.13 | -0.07 | -0.10 |
| EPS Diluted Before Non-Recurring Items | -0.07 | -0.07 | -0.13 | N/A | N/A |
| EBITDA(a) | $-8,412 | $-7,107 | $-10,217 | $-5,612 | $-6,185 |